BFC Planning’s BioLineRX BLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$66 Hold
28
– – ﹤0.01% 3404
2026
Q2
$87 Buy
+28
New +$81 ﹤0.01% 3359

Other funds holding BLRX

BFC Planning's BLRX Position: Q3 2026 in Review

BFC Planning held its BioLineRX (BLRX) position steady in Q3 2026 at 28 shares worth $66. The position accounts for ﹤0.01% of the portfolio, ranked #3404.

BFC Planning first reported a position in BLRX in Q2 2026 and has held it in 2 quarters since. The position peaked at $87 in Q2 2026. 12 funds tracked by Wall St. Rank hold BLRX as of Q3 2026.

  • BFC Planning held 28 shares of BioLineRX worth $66 as of Q3 2026.
  • BFC Planning left its BioLineRX share count unchanged in Q3 2026.
  • BioLineRX made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3404 holding.
  • BFC Planning first reported a position in BioLineRX in Q2 2026 and has held it in 2 quarters since.
  • BFC Planning's BioLineRX position peaked at $87 in Q2 2026.
  • 12 funds tracked by Wall St. Rank held BioLineRX as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.